155 related articles for article (PubMed ID: 20430577)
1. Response times follow lognormal or gamma distribution in arthritis patients.
Abrahamyan L; Beyene J; Feng J; Chon Y; Willan AR; Schmeling H; Horneff G; Keystone EC; Feldman BM
J Clin Epidemiol; 2010 Dec; 63(12):1363-9. PubMed ID: 20430577
[TBL] [Abstract][Full Text] [Related]
2. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
Kameda H; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Takeuchi T;
Mod Rheumatol; 2010 Dec; 20(6):531-8. PubMed ID: 20574649
[TBL] [Abstract][Full Text] [Related]
3. A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
Takeuchi T; Miyasaka N; Zang C; Alvarez D; Fletcher T; Wajdula J; Yuasa H; Vlahos B
Mod Rheumatol; 2013 Jul; 23(4):623-33. PubMed ID: 23011358
[TBL] [Abstract][Full Text] [Related]
4. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
5. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study.
Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T
J Rheumatol; 2011 Aug; 38(8):1585-92. PubMed ID: 21572151
[TBL] [Abstract][Full Text] [Related]
6. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A;
Ann Rheum Dis; 2008 Aug; 67(8):1104-10. PubMed ID: 17666447
[TBL] [Abstract][Full Text] [Related]
9. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study].
He WZ; Yin ZH; Gao JH; Ye ZZ; Xie Y; Kong WH; Chen YS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):267-71. PubMed ID: 24758073
[TBL] [Abstract][Full Text] [Related]
10. Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naïve patients with active rheumatoid arthritis.
Takeuchi T; Miyasaka N; Pedersen R; Sugiyama N; Hirose T
Mod Rheumatol; 2020 Mar; 30(2):259-268. PubMed ID: 30836801
[No Abstract] [Full Text] [Related]
11. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E
Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
[TBL] [Abstract][Full Text] [Related]
12. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept.
Goldman JA; Xia HA; White B; Paulus H
Ann Rheum Dis; 2006 Dec; 65(12):1649-52. PubMed ID: 17105853
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
15. Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Davies R; Southwood TR; Kearsley-Fleet L; Lunt M; Hyrich KL;
Arthritis Rheumatol; 2015 Sep; 67(9):2487-94. PubMed ID: 25989609
[TBL] [Abstract][Full Text] [Related]
16. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
van der Heijde D; Klareskog L
Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
[No Abstract] [Full Text] [Related]
17. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
[TBL] [Abstract][Full Text] [Related]
18. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Buch MH; Bingham SJ; Bejarano V; Bryer D; White J; Reece R; Quinn M; Emery P
Arthritis Rheum; 2007 Apr; 57(3):448-53. PubMed ID: 17394231
[TBL] [Abstract][Full Text] [Related]
19. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
Hu D; Bao C; Chen S; Gu J; Li Z; Sun L; Han X; Ni L
Rheumatol Int; 2009 Jan; 29(3):297-303. PubMed ID: 18704426
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
